Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

被引:0
|
作者
Nobuyuki Amemiya
Takashi Takei
Chiari Kojima
Hirohiko Nokiba
Mitsuyo Itabashi
Kosaku Nitta
机构
[1] Tokyo Women’s Medical University,Department of Medicine, Kidney Center
来源
关键词
Frequently relapsing minimal change nephrotic syndrome; Rituximab; Monotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
Treatment with a single dose of rituximab alone induced remission in a patient with relapsed minimal change nephrotic syndrome (MCNS). A 27-year-old man was given corticosteroid (prednisolone; PSL) and cyclosporine (CyA) therapy combined with rituximab for his fifth relapse in 2008. Thereafter, complete remission was achieved and maintained despite eventual discontinuation of the PSL and CyA. In 2010, we treated his sixth relapse with a single dose of rituximab. Complete remission was obtained 32 days later. This is the first report of rituximab monotherapy in the treatment of MCNS.
引用
收藏
页码:933 / 936
页数:3
相关论文
共 50 条
  • [1] Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome
    Amemiya, Nobuyuki
    Takei, Takashi
    Kojima, Chiari
    Nokiba, Hirohiko
    Itabashi, Mitsuyo
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (06) : 933 - 936
  • [2] Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome
    Niu, Xiao-Ling
    Hao, Sheng
    Wang, Ping
    Zhang, Wei
    Guo, Gui-Mei
    Wu, Ying
    Kuang, Xin-Yu
    Zhu, Guang-Hua
    Huang, Wen-Yan
    BIOMEDICAL REPORTS, 2016, 5 (02) : 237 - 242
  • [3] Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome
    Sawara, Y.
    Itabashi, M.
    Kojima, C.
    Tabata, H.
    Kamei, D.
    Kawanishi, K.
    Moriyama, T.
    Sugiura, H.
    Tsukada, M.
    Takei, T.
    Ogawa, T.
    Yoshida, T.
    Arai, J.
    Uchida, K.
    Tsuchiya, K.
    Nitta, K.
    CLINICAL NEPHROLOGY, 2009, 72 (01) : 69 - 72
  • [4] Successful Use of Single-Dose Rituximab for the Maintenance of Remission in a Patient with Steroid-Resistant Nephrotic Syndrome
    Kurosu, Noritomo
    Sugiura, Hidekazu
    Iwasaki, Chihiro
    Asamiya, Yukari
    Kojima, Chiari
    Moriyama, Takahito
    Itabashi, Mitsuyo
    Tsukada, Misao
    Takei, Takashi
    Ogawa, Tetsuya
    Yoshida, Takumi
    Uchida, Keiko
    Tsuchiya, Ken
    Nitta, Kosaku
    INTERNAL MEDICINE, 2009, 48 (21) : 1901 - 1904
  • [5] Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults
    Takei, Takashi
    Itabashi, Mitsuyo
    Moriyama, Takahito
    Kojima, Chiari
    Shiohira, Syunji
    Shimizu, Ari
    Tsuruta, Yuki
    Ochi, Ayami
    Amemiya, Nobuyuki
    Mochizuki, Toshio
    Uchida, Keiko
    Tsuchiya, Ken
    Nitta, Kosaku
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (05) : 1225 - 1232
  • [6] Rituximab and minimal change nephrotic syndrome: a therapeutic option
    Takei, Takashi
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (05) : 641 - 647
  • [7] Rituximab and minimal change nephrotic syndrome: a therapeutic option
    Takashi Takei
    Kosaku Nitta
    Clinical and Experimental Nephrology, 2011, 15 : 641 - 647
  • [8] A case diagnosed with IgA nephropathy during a complete remission of minimal change nephrotic syndrome treated with rituximab
    Nishikawa, Mana
    Shimada, Noriaki
    Kurahashi, Motoyasu
    Watanabe, Kentaro
    Kanzaki, Motoko
    Fukuoka, Kosuke
    Asano, Kenichiro
    CEN CASE REPORTS, 2024, 13 (06): : 561 - 564
  • [9] Resolution of Nephrotic Syndrome Following Rituximab Therapy in a Patient Undergoing Immune Tolerance Induction
    Peltier, S.
    Heisel-Kurth, M.
    Verghese, P.
    Kearney, S.
    HAEMOPHILIA, 2012, 18 : 93 - 94
  • [10] Minimal change nephrotic syndrome in a patient with strongyloidiasis
    Miyazaki, Mieko
    Tamura, Masahito
    Kabashima, Narutoshi
    Serino, Ryota
    Shibata, Tatsuya
    Miyamoto, Tetsu
    Furuno, Yumi
    Nishio, Tetsuo
    Ohara, Jiro
    Sakurai, Toshihiro
    Otsuji, Yutaka
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (04) : 367 - 371